NASDAQ:MDXH MDxHealth (MDXH) Stock Price, News & Analysis $1.60 +0.06 (+3.56%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.56 -0.04 (-2.44%) As of 04/17/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About MDxHealth Stock (NASDAQ:MDXH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MDxHealth alerts:Sign Up Key Stats Today's Range$1.55▼$1.6050-Day Range$1.41▼$1.9552-Week Range$1.35▼$3.50Volume13,450 shsAverage Volume82,109 shsMarket Capitalization$75.66 millionP/E RatioN/ADividend YieldN/APrice Target$6.50Consensus RatingBuy Company OverviewMDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. The company offers genomic prostate score which provides personalized genomic insights to both physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. It sells its products through urology sales force, consisting of direct sales representatives, strategic account managers, and regional sales managers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.Read More… MDxHealth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks60th Percentile Overall ScoreMDXH MarketRank™: MDxHealth scored higher than 60% of companies evaluated by MarketBeat, and ranked 530th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingMDxHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMDxHealth has received no research coverage in the past 90 days.Read more about MDxHealth's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for MDxHealth are expected to grow in the coming year, from ($1.15) to ($0.61) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MDxHealth is -1.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MDxHealth is -1.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMDxHealth has a P/B Ratio of 0.35. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about MDxHealth's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.16% of the float of MDxHealth has been sold short.Short Interest Ratio / Days to CoverMDxHealth has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MDxHealth has recently decreased by 40.67%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMDxHealth does not currently pay a dividend.Dividend GrowthMDxHealth does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.16% of the float of MDxHealth has been sold short.Short Interest Ratio / Days to CoverMDxHealth has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MDxHealth has recently decreased by 40.67%, indicating that investor sentiment is improving significantly. News and Social Media2.8 / 5News SentimentN/A News SentimentMDxHealth has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for MDxHealth this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, MDxHealth insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.70% of the stock of MDxHealth is held by insiders.Read more about MDxHealth's insider trading history. Receive MDXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address MDXH Stock News HeadlinesLake Street Reaffirms Their Buy Rating on MDxHealth (MDXH)April 5, 2025 | markets.businessinsider.comMDxHealth management to meet with Lake StreetMarch 27, 2025 | markets.businessinsider.comSomething strange going on at Mar-a-LagoA former government advisor says a $9 trillion AI breakthrough is nearing launch. It may become America’s biggest advantage in the race against China — and a handful of Musk-linked companies could benefit.April 18, 2025 | Brownstone Research (Ad)Earnings call transcript: MDxHealth beats Q4 2024 EPS forecast, stock risesFebruary 28, 2025 | investing.comMdxhealth Announces Fourth Quarter and Full-Year 2024 Financial ResultsFebruary 26, 2025 | globenewswire.comMdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26February 12, 2025 | markets.businessinsider.comPiper Sandler Sticks to Its Buy Rating for MDxHealth (MDXH)January 15, 2025 | markets.businessinsider.comMDxHealth sees FY25 revenue $108M-$110M, consensus $98.93MJanuary 14, 2025 | markets.businessinsider.comSee More Headlines MDXH Stock Analysis - Frequently Asked Questions How have MDXH shares performed this year? MDxHealth's stock was trading at $2.37 on January 1st, 2025. Since then, MDXH stock has decreased by 32.5% and is now trading at $1.60. View the best growth stocks for 2025 here. How were MDxHealth's earnings last quarter? MDxHealth SA (NASDAQ:MDXH) issued its quarterly earnings results on Wednesday, February, 26th. The company reported ($0.14) EPS for the quarter, beating analysts' consensus estimates of ($0.21) by $0.07. The company had revenue of $24.74 million for the quarter, compared to analyst estimates of $22.67 million. MDxHealth had a negative trailing twelve-month return on equity of 1,077.84% and a negative net margin of 49.52%. Read the conference call transcript. When did MDxHealth's stock split? Shares of MDxHealth reverse split on Friday, December 29th 2023. The 1-10 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did MDxHealth IPO? MDxHealth (MDXH) raised $45 million in an initial public offering (IPO) on Thursday, November 4th 2021. The company issued 3,750,000 shares at $12.00 per share. How do I buy shares of MDxHealth? Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MDxHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that MDxHealth investors own include Cognition Therapeutics (CGTX), LAVA Therapeutics (LVTX), Coeptis Therapeutics (COEP), PHX Minerals (PHX), PayPal (PYPL), Arcadia Biosciences (RKDA) and Alimera Sciences (ALIM). Company Calendar Last Earnings2/26/2025Today4/18/2025Next Earnings (Estimated)5/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:MDXH CIK1872529 Webmdxhealth.com Phone324-364-2070Fax32042597875Employees300Year FoundedN/APrice Target and Rating Average Stock Price Target$6.50 High Stock Price Target$7.00 Low Stock Price Target$6.00 Potential Upside/Downside+306.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-43,100,000.00 Net Margins-49.52% Pretax Margin-49.12% Return on Equity-1,077.84% Return on Assets-28.82% Debt Debt-to-Equity Ratio3.14 Current Ratio1.54 Quick Ratio1.45 Sales & Book Value Annual Sales$90.05 million Price / Sales0.84 Cash FlowN/A Price / Cash FlowN/A Book Value$4.62 per share Price / Book0.35Miscellaneous Outstanding Shares47,288,000Free Float46,484,000Market Cap$75.66 million OptionableNot Optionable Beta1.29 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:MDXH) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MDxHealth SA Please log in to your account or sign up in order to add this asset to your watchlist. Share MDxHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.